Evidence map›Paper›PMID 25113789›Full record

ArticleBrain : a journal of neurology2014

The evolution of primary progressive apraxia of speech.

Keith A Josephs, Joseph R Duffy, Edythe A Strand, Mary M Machulda, Matthew L Senjem, Jeffrey L Gunter, Christopher G Schwarz, Robert I Reid, Anthony J Spychalla, Val J Lowe and 2 more

Open access · greenAbstract read
In one paragraph

Article in Brain : a journal of neurology, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 101 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
101citing papers in PubMed, 1 pooled it
5.6field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

101 citing papers in PubMed, 1 synthesis or guideline pooled it, 165 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Review
  17. Review
  18. Word Count Matters: Features of Written Language Production in Progressive Apraxia of Speech with and without Agrammatism.Folia phoniatrica et logopaedica : official organ of the International Association of Logopedics and Phoniatrics (IALP) · 2025
    Article
  19. Progression of Motor Speech Function in Speakers With Primary Progressive Apraxia of Speech.Journal of speech, language, and hearing research : JSLHR · 2024
    Article
  20. Article

41 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 3 institutions in 1 country.

Keith A Josephs1 Department of Neurology (Behavioural Neurology), Mayo Clinic, Rochester, MN 55905, USA 2 Department of Neurology (Movement Disorders), Mayo Clinic, Rochester, MN 55905, USA Josephs.keith@mayo.edu.
Joseph R Duffy3 Department of Neurology (Speech Pathology), Mayo Clinic, Rochester, MN 55905, USA.
Edythe A Strand3 Department of Neurology (Speech Pathology), Mayo Clinic, Rochester, MN 55905, USA.
Mary M Machulda4 Department of Psychiatry and Psychology (Neuropsychology), Mayo Clinic, Rochester, MN 55905, USA.
Matthew L Senjem5 Department of Information Technology, Mayo Clinic, Rochester, MN 55905, USA.
Jeffrey L Gunter5 Department of Information Technology, Mayo Clinic, Rochester, MN 55905, USA.
Christopher G Schwarz6 Department of Radiology (Neuroradiology), Mayo Clinic, Rochester, MN 55905, USA.
Robert I Reid6 Department of Radiology (Neuroradiology), Mayo Clinic, Rochester, MN 55905, USA.
Anthony J Spychalla6 Department of Radiology (Neuroradiology), Mayo Clinic, Rochester, MN 55905, USA.
Val J Lowe7 Department of Radiology (Nuclear Medicine), Mayo Clinic, Rochester, MN 55905, USA.
Clifford R Jack6 Department of Radiology (Neuroradiology), Mayo Clinic, Rochester, MN 55905, USA.
Jennifer L Whitwell6 Department of Radiology (Neuroradiology), Mayo Clinic, Rochester, MN 55905, USA.
Mayo Clinic in Arizona · USMayo Clinic · USWinnMed · US

Funding

Longitudinal multi-modality imaging in progressive apraxia of speech (Diversity Supplement)R01DC012519 · NIDCD · MAYO CLINIC ROCHESTER · PI Jennifer Louise Whitwell · 2013 to 2026
$7.2M
PIB PET Scanning in Speech and Language Based DementiasR01DC010367 · NIDCD · MAYO CLINIC ROCHESTER · PI JOSEPHS, KEITH A · 2010 to 2014
$1.7M
NIDCD NIH HHS R01 DC010367NIDCD NIH HHS R01 DC012519
6 · The paper itself

Abstract

Primary progressive apraxia of speech is a recently described neurodegenerative disorder in which patients present with an isolated apraxia of speech and show focal degeneration of superior premotor cortex. Little is known about how these individuals progress over time, making it difficult to provide prognostic estimates. Thirteen subjects with primary progressive apraxia of speech underwent two serial comprehensive clinical and neuroimaging evaluations 2.4 years apart [median age of onset = 67 years (range: 49-76), seven females]. All underwent detailed speech and language, neurological and neuropsychological assessments, and magnetic resonance imaging, diffusion tensor imaging and (18)F-fluorodeoxyglucose positron emission tomography at both baseline and follow-up. Rates of change of whole brain, ventricle, and midbrain volumes were calculated using the boundary-shift integral and atlas-based parcellation, and rates of regional grey matter atrophy were assessed using tensor-based morphometry. White matter tract degeneration was assessed on diffusion-tensor imaging at each time-point. Patterns of hypometabolism were assessed at the single subject-level. Neuroimaging findings were compared with a cohort of 20 age, gender, and scan-interval matched healthy controls. All subjects developed extrapyramidal signs. In eight subjects the apraxia of speech remained the predominant feature. In the other five there was a striking progression of symptoms that had evolved into a progressive supranuclear palsy-like syndrome; they showed a combination of severe parkinsonism, near mutism, dysphagia with choking, vertical supranuclear gaze palsy or slowing, balance difficulties with falls and urinary incontinence, and one was wheelchair bound. Rates of whole brain atrophy (1.5% per year; controls = 0.4% per year), ventricular expansion (8.0% per year; controls = 3.3% per year) and midbrain atrophy (1.5% per year; controls = 0.1% per year) were elevated (P ≤ 0.001) in all 13, compared to controls. Increased rates of brain atrophy over time were observed throughout the premotor cortex, as well as prefrontal cortex, motor cortex, basal ganglia and midbrain, while white matter tract degeneration spread into the splenium of the corpus callosum and motor cortex white matter. Hypometabolism progressed over time in almost all subjects. These findings demonstrate that some subjects with primary progressive apraxia of speech will rapidly evolve and develop a devastating progressive supranuclear palsy-like syndrome ∼ 5 years after onset, perhaps related to progressive involvement of neocortex, basal ganglia and midbrain. These findings help improve our understanding of primary progressive apraxia of speech and provide some important prognostic guidelines.

Indexed as

AgedAge of OnsetBrainCognitionDiffusion Tensor ImagingDisease ProgressionEducational StatusFemaleFluorodeoxyglucose F18HumansImage Processing, Computer-AssistedMagnetic Resonance ImagingMaleMiddle AgedNeuroimagingNeurologic ExaminationFluorodeoxyglucose F18Radiopharmaceuticalsdisease progressionmagnetic resonance imagingnon-fluent speechparkinsonismprogressive supranuclear palsy

Identifiers

PMID25113789
PMCPMC4229741
OpenAlexW2046616378

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.